Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Wearing-off scales in Parkinson's disease: critique and recommendations.
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline.
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial.
APOE e4 increases risk for dementia in pure synucleinopathies.
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
APOE e4 increases risk for dementia in pure synucleinopathies.
APOE e4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013 Feb; 70(2):223-8.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Alzheimer Disease
Apolipoprotein E4
Case-Control Studies
Dementia
Female
Gene Frequency
Humans
Lewy Body Disease
Longitudinal Studies
Male
Middle Aged
Parkinson Disease
Retrospective Studies
Risk Factors
Synucleins
Up-Regulation
authors with profiles
Julie A Schneider
David A Bennett
Aron S Buchman